|Description||Medtech Venture Capital Fund|
|French fund I, 1/10||€100M|
NBGI Ventures is a leading venture capital fund focused on investing in exceptional medical technology companies. Established in 2001, NBGI Ventures currently manage two funds with over $100 million in total commitments and invest from greenfield start-ups to mature companies.
NBGI Ventures have offices in London and Athens, and have invested in a portfolio of companies across Europe in all med-tech subsectors. The investment team consists of experienced, down-to-earth and active professionals committed to identifying innovators and supporting their growth.
NBGI Ventures is part of the NBGI Private Equity group, a leading European private equity and venture capital investment firm managing approximately â‚¬800 million.
|SuperSonic Imagine||4/13||Private Equity||€28M||9|
|SuperSonic Imagine||11/10||Series C||€34.5M||6|
|Reverse Medical||4/10||Series B||$14M||6|
|Advanced Cardiac Therapeutics||1/10||Series B||$5M||1|
|Quanta Fluid Solutions||11/09||Series A||$14.3M||4|
|Upfront Chromatography||9/07||Venture Round||$9.2M||3|